Goldman Sachs Group »

Vistagen Therapeutics Ord shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $609k 175k 3.48
2024-03-31 $877k 166k 5.28
2023-12-31 $842k 164k 5.14
2023-06-30 $107k 57k 1.87